CTC
HALO icon

Cetera Trust Company’s Halozyme HALO Stock Holding History

Cetera Trust Company’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Hold
6,200
– – 0.23% 85
2025
Q4 		$417K Hold
6,200
– – 0.22% 82
2025
Q3 		$455K Hold
6,200
– – 0.25% 72
2025
Q2 		$323K Buy
6,200
+425
+7% +$24.2K 0.19% 94
2025
Q1 		$369K Buy
5,775
+150
+3% +$8.71K 0.23% 73
2024
Q4 		$269K Buy
5,625
+85
+2% +$4.36K 0.17% 110
2024
Q3 		$317K Hold
5,540
– – 0.19% 99
2024
Q2 		$290K Hold
5,540
– – 0.18% 98
2024
Q1 		$225K Sell
5,540
-100
-2% -$3.75K 0.14% 146
2023
Q4 		$208K Buy
+5,640
New +$212K 0.13% 145

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Trust Company's HALO Position: Q1 2026 in Review

Cetera Trust Company held its Halozyme (HALO) position steady in Q1 2026 at 6,200 shares worth $401K. The position accounts for 0.23% of the portfolio, ranked #85.

Cetera Trust Company first reported a position in HALO in Q4 2023 and has held it in 10 quarters since. The position peaked at $455K in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Cetera Trust Company held 6,200 shares of Halozyme worth $401K as of Q1 2026.
  • Cetera Trust Company left its Halozyme share count unchanged in Q1 2026.
  • Halozyme made up 0.23% of Cetera Trust Company's portfolio in Q1 2026, its #85 holding.
  • Cetera Trust Company first reported a position in Halozyme in Q4 2023 and has held it in 10 quarters since.
  • Cetera Trust Company's Halozyme position peaked at $455K in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.